Helus Pharma Inc. (HELP) stock
HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
$8.86−0.53 (-5.64%)
Close on Nov 12, 2026Market cap $457.46MP/E –Yield –
Helus Pharma EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2023 it was -9.88 CAD.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | -9.88 CAD | – |
| FY2022 | Mar 31, 2022 | -15.20 CAD | – |
| FY2021 | Mar 31, 2021 | -12.16 CAD | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?